WAR:SCP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
WAR:SCP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Scope Fluidics Spolka Akcyjna WAR:SCP
Scope Fluidics Spolka Akcyjna WAR:SCP -0.84% 50 Book Value per Share is zł47.02 as of Mar. 2026. GuruFocus rates WAR:SCP with a GF Score™ of 50/100 and a GF Value™ of zł128.17 (Fairly Valued). The stock has 4 warning signs investors should review.
Scope Fluidics Spolka Akcyjna's book value per share for the quarter that ended in Mar. 2026 was zł47.02.
During the past 12 months, Scope Fluidics Spolka Akcyjna's average Book Value Per Share Growth Rate was -5.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -25.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 60.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Scope Fluidics Spolka Akcyjna was 177.60% per year. The lowest was -25.10% per year. And the median was 38.80% per year.
Scope Fluidics Spolka Akcyjna's current price is zł118.00. Its book value per share for the quarter that ended in Mar. 2026 was zł47.02. Hence, today's PB Ratio of Scope Fluidics Spolka Akcyjna is 2.51.
During the past 10 years, the highest P/B Ratio of Scope Fluidics Spolka Akcyjna was 31.55. The lowest was 1.38. And the median was 6.40.
Good Sign:
Scope Fluidics Spolka Akcyjna stock PB Ratio (=2.51) is close to 3-year low of 2.48.
Scope Fluidics Spolka Akcyjna (WAR:SCP) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
The historical data trend for Scope Fluidics Spolka Akcyjna's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Scope Fluidics Spolka Akcyjna Annual Data | |||||||||||||||||||||
| Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | Dec25 | |||||||||||
| Book Value per Share | Get a 7-Day Free Trial |
|
|
2.51 | 122.15 | 29.69 | 53.69 | 51.27 | |||||||||||||
| Scope Fluidics Spolka Akcyjna Quarterly Data | ||||||||||||||||||||
| Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | |
| Book Value per Share | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
49.65 | 46.52 | 42.35 | 51.27 | 47.02 | ||
For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's PB Ratio distribution charts can be found below:
* The bar in red indicates where Scope Fluidics Spolka Akcyjna's PB Ratio falls into.
Scope Fluidics Spolka Akcyjna's Book Value Per Share for the fiscal year that ended in Dec. 2025 is calculated as:
| Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
| = | (162.43 | - | 0.00) | / | 3.17 | |
| = | 51.27 |
Scope Fluidics Spolka Akcyjna's Book Value Per Share for the quarter that ended in Mar. 2026 is calculated as:
| Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
| = | (148.96 | - | 0.00) | / | 3.17 | |
| = | 47.02 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of zł118.00 is trading 7.9% below its estimated GF Value™ of zł128.17. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.
Key valuation signals for WAR:SCP:
No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.